Filed in 2022, this patent describes "a ring-shaped strip of stretchable ... readings. ECG data offers insight into the heart ...

Routine ECG recorded through noninvasive, cheap and easily available tolls have markers that portend higher stroke risk. Atrial fibrillation (AF) is the most common clinical arrhythmia ...

Share on Pinterest While a modest amount of physical activity may help lower AFib risk, more exercise offers greater protection. SolStock/Getty Images New research indicates that one hour of ...

The Apple Watch ECG app is a powerful tool for monitoring your heart health. It provides valuable insights and can potentially detect serious conditions like AFib. The ability to take an ECG ...

A single hour of exercise per week can cut your risk of developing atrial fibrillation, according to new research. The findings build on prior evidence suggesting that exercise, even at minimum ...

They discovered that people who had higher levels of weekly physical activity were less likely to develop atrial fibrillation. ‘I Walked for 30 Minutes Every Day for a Month’ These Walking ...

After multiple medical procedures starting in May 2022, Arthur Schiebel was pleased to have his atrial fibrillation under control. He was less pleased to find out he’d need to take blood ...

Atrial fibrillation (AFib) is an irregular and often rapid heart rhythm. The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing ...

SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...

Individuals who intend to improve their cardiovascular health often use Magnesium supplements, particularly those dealing with atrial fibrillation (afib). Afib is a condition marked by an ...

Last month a 33-year-old woman in Xi’an, in central China, posted a video on social media that showed snowflakes falling on the ancient city. It was early in the year for such weather, so ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...